|
|
Kendle International Inc. - Comparative Business Analysis Snapshot
Business Description
Kendle International Inc.. The Group's principal activity is to provides Phase I-IV global clinical development services to the biopharmaceutical industry. It operates in two segments: Early Stage and Late Stage. The Early Stage segment focuses on the Group's Phase I operations, the high-end scientific exploratory medicine area. The Late Stage is comprised of clinical development services related to Phases II through IV, includes four reporting units: Global Clinical Development, Late Phase, Regulatory Affairs and Quality and Biometrics. The Global Clinical Development unit conducts Phase II and III clinical trials worldwide. The Late Phase unit designs and conducts Phase IIIB and IV studies worldwide. The Regulatory Affairs and Quality unit provides regulatory expertise and consulting services.The Biometrics unit offers customized clinical data management. It operates in the United States, Europe, Asia Pacific and Africa. In June 2008, it acquired DecisionLine Clinical Research Corporation.
Competitor Analysis
This analysis compares Kendle International Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
